Used in the synthesis of antiviral agents, particularly in the development of nucleoside analogs that inhibit viral replication. It serves as a key intermediate in creating compounds active against RNA viruses, including certain strains of hepatitis and influenza. Its structure mimics natural nucleosides, allowing it to interfere with viral polymerase enzymes, thereby terminating the elongation of viral RNA chains. This compound is also explored in medicinal chemistry for potential use in prodrug formulations to enhance bioavailability and targeted delivery.